Anticancer agent 188
Anticancer agent 188 (compound D43) inhibits DNA synthesis in TNBC cells, leading to cell cycle arrest at the G2/M phase. Anticancer agent 188 has anti-cancer viability by inducing ROS-mediated apoptosis and DNA damage[1].
Product Specifications
CAS Number
1207377-56-7
UNSPSC
12352005
Target
DNA/RNA Synthesis; Reactive Oxygen Species (ROS)
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/anticancer-agent-188.html
Purity
99.10
Solubility
DMSO : 50 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
CN1C(C2=NC(C3=C(F)C=CC=C3)=N1)=NC(N(C)C2=O)=O
Molecular Formula
C13H10FN5O2
Molecular Weight
287.25
References & Citations
[1]Tingyue Wu, et al. Toxoflavin analog D43 exerts antiproliferative effects on breast cancer by inducin. Sci Rep. 2024, 14, 1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
6530409C15Rik Mouse siRNA Oligo Duplex (Locus ID 76224)
Cytokeratin 19 (BA17), CF640R conjugate, 0.1mg/mL